- Home
- » Tags
- » Calanolide A
Top View
- WO 2013/116720 Al 8 August 2013 (08.08.2013) P O P C T
- Naturally Occurring Calanolides: Occurrence, Biosynthesis, and Pharmacological Properties Including Therapeutic Potential
- Ccr5 Antagonists Useful for Treating Aids Ccr5 Antagonisten Verwendbar Für Die Behandlung Von Aids Antagonistes De Ccr5 Utiles Dans Le Traitement Du Sida
- In Silico Study of Various Antiviral Drugs, Vitamins, and Natural Substances
- HIV Reverse Transcriptase Inhibitors of Natural Origin
- (12) United States Patent (10) Patent No.: US 9,708,342 B2 Carra Et Al
- (+)-Calanolide a of Wild-Type and Mutated Forms of HIV-1 Reverse Transcriptase
- Full Paper In
- Computational Drug Design Strategies Applied to the Modelling of Human Immunodeficiency Virus-1 Reverse Transcriptase Inhibitors
- COVID User's Guide (Updated: 14/12/2020)
- Non-Nucleoside Reverse Transcriptase Inhibitors In
- 2013 Pipeline Report
- Recent Developments in HIV Treatment and Their Dissemination in Poor
- Computational Studies of HIV-1 Protease Inhibitors
- Natural Products As Anti-HIV Agents and Role in HIV-Associated Neurocognitive Disorders
- HIV, HCV, TB: 2012 Pipeline Report, TAG and I-Base
- Twenty-Six Years of Anti-HIV Drug Discovery: Where Do We Stand and Where Do We Go?
- Naturally Occurring Calanolides: Occurrence, Biosynthesis, And
- 45PYRAZINO2,1-B1.3OXAZEPINES E. : It
- WO 2018/193470 Al 25 October 2018 (25.10.2018) W !P O PCT
- 2011 Pipeline Report Second Edition
- World Journal of Virology